Randomized controlled trial of 2% lidocaine gel versus water-based lubricant for multi-channel urodynamics.

INTRODUCTION AND HYPOTHESIS: The purpose of the study was to determine if there is a difference in pain during and after multichannel urodynamic testing in women when using 2% lidocaine gel versus water-based lubricant. METHODS: This was a randomized, controlled, double-blinded study. Women scheduled to undergo urodynamic testing were invited to participate. Participants were randomized to lidocaine 2% gel or water-based lubricant for use during testing. Both participant and examiner were blinded to the type of gel. Pain was assessed by the Wong-Baker pain scale from 0 to 10 at four points during the examination. After testing, participants completed a questionnaire to assess their expectations of pain and embarrassment with urodynamic testing. The examiner also completed a questionnaire to assess his/her impression of the participant's pain during the procedure. RESULTS: The women in the lidocaine group had lower pain scores after the cotton tipped swab test (1.3 vs 3.6, lidocaine vs lubricant respectively, p < 0.001) and after placement of urodynamic catheters (1.4 vs 3.9, lidocaine vs lubricant, respectively, p < 0.001). Mean pain scores 30 min post-completion of the study were similar between groups (0.7 vs 1.2, 1.4 vs 3.9, lidocaine vs lubricant respectively, p = 0.19). Participants reported that pain during the study was better than expected in both groups. Physician perception of the participant's pain during testing was lower in the lidocaine group (2 vs 3, lidocaine vs lubricant respectively p = 0.008). CONCLUSION: Use of 2% lidocaine gel during in and out catheterization, cotton-tipped swab test, and urodynamic testing decreases pain during these procedures.

Benign cystic ovarian teratoma with a fistula into the small and large bowel.

BACKGROUND: Ovarian dermoid cysts are one of the most common benign neoplasms in women. Rarely, serious complications occur that result in life-threatening events such as bowel perforation. This case summarizes one of these complications from clinical presentation to diagnosis and treatment. CASE: A 25-year-old woman with symptoms of small bowel obstruction was found to have a 10-cm dermoid cyst perforating into both her small and large bowel. A primary large bowel repair and small bowel resection with en bloc left salpingo-oophorectomy and small bowel side-to-side reanastomosis was performed. CONCLUSION: This case illustrates the rare formation of a fistula between a dermoid cyst and the small and large bowel. Awareness of the clinical and radiologic findings in these cases is important to avoid further complications.

Randomized trial of estradiol vaginal ring versus oral oxybutynin for the treatment of overactive bladder.

OBJECTIVE: The aim of this study was to compare the efficacy of the ultralow-dose estradiol vaginal ring with that of oral oxybutynin in the treatment of overactive bladder in postmenopausal women. METHODS: Postmenopausal women with an overactive bladder were recruited from the general gynecology clinic. Participants were randomized to receive either the ultralow-dose estradiol vaginal ring or oral oxybutynin for 12 weeks. The primary outcome was a decrease in the number of voids in 24 hours. The secondary outcomes were quality-of-life questionnaires, vaginal pH levels, and vaginal maturation index. RESULTS: Fifty-nine women were enrolled. Thirty-one were randomized to receive oxybutynin, whereas 28 received the estradiol vaginal ring. Women who received oxybutynin had a mean decrease of 3.0 voids per day, and women who received the vaginal ring had a mean decrease of 4.5 voids per day, with no significant difference between the groups. There was a significant improvement in Urogenital Distress Inventory and Incontinence Impact Questionnaire scores in both groups, with no significant difference in improvement between the two groups. CONCLUSIONS: Ultralow-dose estradiol-releasing vaginal ring and oral oxybutynin seem to be similarly effective in decreasing the number of daily voids in postmenopausal women with overactive bladder.

Colorectal and anal symptoms in women with urinary incontinence and pelvic organ prolapse.

INTRODUCTION AND HYPOTHESIS: Our aim was to determine the prevalence of colorectal and anal (CRA) symptoms in women with urinary incontinence and pelvic organ prolapse (UI/POP) in a predominantly Latina population. METHODS: We reviewed charts of women seen in the urogynecology clinic for UI/POP for those who completed the colorectal anal distress inventory-8 (CRADI-8) on their first visit. A detailed history was taken independent of the questionnaire. RESULTS: Two hundred sixty-five women completed the questionnaire; 94% were Latina; 89% completed the questionnaire in Spanish. Of the women, 88% indicated at least one CRA symptom: 60% reported needing to strain hard to have a bowel movement; 59% reported sensation of incomplete bowel emptying; 21% indicated incontinence of solid or liquid stool, and an additional 30% of women reported flatal incontinence only, for a total anal incontinence rate of 58%. CONCLUSION: CRA symptoms are highly prevalent among women with UI/POP who completed the CRADI-8 in a predominantly Latina patient population.